Item 1.02. Termination of a Material Definitive Agreement.
On
Item 7.01. Regulation FD Disclosure.
A copy of the press release referenced above is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information under this Item 7.01, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press Release issued byRubius Therapeutics, Inc. onMay 24, 2022 , furnished herewith. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
© Edgar Online, source